COL9A3
Basic information
Region (hg38): 20:62816244-62841159
Links
Phenotypes
GenCC
Source:
- epiphyseal dysplasia, multiple, 3 (Moderate), mode of inheritance: AD
- epiphyseal dysplasia, multiple, 3 (Definitive), mode of inheritance: AD
- Stickler syndrome (Strong), mode of inheritance: AR
- epiphyseal dysplasia, multiple, 3 (Moderate), mode of inheritance: AD
- multiple epiphyseal dysplasia due to collagen 9 anomaly (Supportive), mode of inheritance: AD
- autosomal recessive Stickler syndrome (Supportive), mode of inheritance: AR
- Stickler syndrome (Limited), mode of inheritance: AR
- stickler syndrome, IIa 6 (Definitive), mode of inheritance: AR
- epiphyseal dysplasia, multiple, 3 (Strong), mode of inheritance: AD
- stickler syndrome, IIa 6 (Strong), mode of inheritance: AR
- Stickler syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Stickler syndrome, type VI | AR | Audiologic/Otolaryngologic; Ophthalmologic | Though the condition may be recognizable, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Avoidance of risk factors related to ocular manifestations (eg, contact sports) is indicated | Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Ophthalmologic | 10090888; 10655510; 15551337; 20301302; 24273071; 30450842; 31090205; 33570243; 35241111 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (17 variants)
- Stickler syndrome, IIa 6 (3 variants)
- Epiphyseal dysplasia, multiple, 3 (1 variants)
- Epiphyseal dysplasia, multiple, 3, with myopathy (1 variants)
- Inborn genetic diseases (1 variants)
- Stickler syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL9A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 217 | 232 | ||||
missense | 480 | 20 | 509 | |||
nonsense | 14 | |||||
start loss | 0 | |||||
frameshift | 19 | |||||
inframe indel | 28 | 29 | ||||
splice donor/acceptor (+/-2bp) | 19 | 24 | ||||
splice region | 2 | 52 | 64 | 2 | 120 | |
non coding | 308 | 91 | 408 | |||
Total | 18 | 10 | 552 | 546 | 109 |
Highest pathogenic variant AF is 0.0000198
Variants in COL9A3
This is a list of pathogenic ClinVar variants found in the COL9A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-62817046-G-T | Likely benign (Mar 11, 2020) | |||
20-62817069-C-A | Inborn genetic diseases | Uncertain significance (Jul 06, 2021) | ||
20-62817069-C-T | Uncertain significance (Aug 12, 2022) | |||
20-62817070-CG-C | Pathogenic (Oct 04, 2022) | |||
20-62817071-G-C | Uncertain significance (Jan 05, 2024) | |||
20-62817074-C-G | Uncertain significance (Dec 11, 2020) | |||
20-62817075-C-T | Uncertain significance (Jan 31, 2024) | |||
20-62817077-C-A | Uncertain significance (Jun 14, 2022) | |||
20-62817077-C-T | Uncertain significance (Jan 08, 2023) | |||
20-62817079-C-T | Likely benign (Nov 19, 2023) | |||
20-62817081-C-T | Uncertain significance (Jul 06, 2022) | |||
20-62817082-G-A | Likely benign (Jun 16, 2023) | |||
20-62817082-G-T | Likely benign (Nov 10, 2022) | |||
20-62817083-T-A | COL9A3-related disorder | Benign/Likely benign (Jan 05, 2024) | ||
20-62817085-C-T | Likely benign (Apr 26, 2023) | |||
20-62817086-G-A | Uncertain significance (Mar 10, 2023) | |||
20-62817087-C-T | Uncertain significance (Dec 31, 2022) | |||
20-62817089-C-T | Inborn genetic diseases | Uncertain significance (Nov 19, 2023) | ||
20-62817090-C-G | Uncertain significance (Oct 26, 2022) | |||
20-62817090-C-T | Uncertain significance (Mar 17, 2023) | |||
20-62817090-CGCTCCT-C | Uncertain significance (Aug 23, 2022) | |||
20-62817091-G-T | Likely benign (Apr 06, 2023) | |||
20-62817090-C-CGCTCCT | COL9A3-related disorder | Uncertain significance (Dec 19, 2023) | ||
20-62817090-C-CGCTCCTGCTCCT | Uncertain significance (Jun 20, 2022) | |||
20-62817092-C-G | Uncertain significance (Mar 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COL9A3 | protein_coding | protein_coding | ENST00000343916 | 32 | 24916 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.28e-12 | 0.999 | 125688 | 0 | 60 | 125748 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.382 | 471 | 448 | 1.05 | 0.0000293 | 4119 |
Missense in Polyphen | 186 | 192.84 | 0.96454 | 1756 | ||
Synonymous | -2.33 | 231 | 190 | 1.21 | 0.0000144 | 1544 |
Loss of Function | 3.00 | 27 | 49.9 | 0.541 | 0.00000303 | 525 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000610 | 0.000598 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000273 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000255 | 0.000246 |
Middle Eastern | 0.000273 | 0.000272 |
South Asian | 0.000362 | 0.000359 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Structural component of hyaline cartilage and vitreous of the eye.;
- Disease
- DISEASE: Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10090888, ECO:0000269|PubMed:25381065}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:11308397, ECO:0000269|PubMed:25381065}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease is conferred by variant p.Arg103Trp (PubMed:11308397). {ECO:0000269|PubMed:11308397}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Protein digestion and absorption - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Gastric Cancer Network 2;PI3K-Akt Signaling Pathway;Developmental Biology;Assembly of collagen fibrils and other multimeric structures;Signal Transduction;Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Collagen degradation;Signaling by PDGF;Collagen formation;Extracellular matrix organization;Integrin;Degradation of the extracellular matrix;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;ECM proteoglycans;Signaling by Receptor Tyrosine Kinases
(Consensus)
Intolerance Scores
- loftool
- 0.0916
- rvis_EVS
- 0.61
- rvis_percentile_EVS
- 82.97
Haploinsufficiency Scores
- pHI
- 0.498
- hipred
- N
- hipred_score
- 0.413
- ghis
- 0.446
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.808
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Col9a3
- Phenotype
Gene ontology
- Biological process
- male gonad development;female gonad development;extracellular matrix organization
- Cellular component
- extracellular region;collagen type IX trimer;extracellular space;endoplasmic reticulum lumen;extracellular matrix
- Molecular function
- extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength